NASDAQ: TRAW
Traws Pharma Inc Stock Ownership - Who owns Traws Pharma?

Insider buying vs selling

Have Traws Pharma Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when TRAW insiders and whales buy or sell their stock.

TRAW Shareholders

What type of owners hold Traws Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Michael B. Hoffman86.50%6,911,786$14.58MInsider
Jane Hoffman 2013 Descendants Michael56.54%4,518,275$9.53MInsider
Nikolay Savchuk33.55%2,681,238$5.66MInsider
Gmbh Baxalta32.58%2,603,295$5.49MInsider
Iain D. Dukes22.73%1,816,230$3.83MInsider
Armistice Capital LLC20.70%1,653,902$3.49MInsider
Orbimed Advisors LLC20.61%1,647,261$3.48MInsider
Viriom Inc20.59%1,645,100$3.47MInsider
Adage Capital Partners GP LLC9.14%730,000$1.54MInstitution
Squadron Capital Management LLC8.93%713,540$1.51MInstitution

1 of 3

TRAW vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TRAW11.74%88.26%
LIXT12.07%87.93%
CTXR7.69%2.52%
LEXX6.84%3.28%Net Buying
QCLS9.32%90.68%

Traws Pharma Stock Ownership FAQ

Who owns Traws Pharma?

Traws Pharma (NASDAQ: TRAW) is owned by 42.78% institutional shareholders, 321.58% Traws Pharma insiders, and 0.00% retail investors. Michael B. Hoffman is the largest individual Traws Pharma shareholder, owning 6.91M shares representing 86.50% of the company. Michael B. Hoffman's Traws Pharma shares are currently valued at $15.21M.

If you're new to stock investing, here's how to buy Traws Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.